Skip to main content
. 2017 Aug 6;8(40):66925–66939. doi: 10.18632/oncotarget.19963

Figure 7. Mitochondrial complex V proteins are associated with poor clinical outcome in ovarian cancer patients.

Figure 7

Note that high levels of ATP5C and ATP5G3 predict significantly reduced overall survival.